Schedule 13D ownership disclosure

Vera Therapeutics Inc

Security class unavailable · CUSIP: 92337R101

Event date: 2021-05-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,914,776
Percent of class
14.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-071020
Form type
SC 13D
Filer
Sofinnova Venture Partners X, L.P.
CIK
CIK 1680200
Filed
May 24, 2021
Reporting period
May 18, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub